Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gilquin

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
AIDS (London, England)|June 10, 1998
Discrepant responses to triple combination antiretroviral therapy in advanced HIV diseaseC Piketty, P Castiel, L Belec, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavirT Bommenel, O Launay, J L Meynard, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
AIDS (London, England)|June 10, 1998
Discrepant responses to triple combination antiretroviral therapy in advanced HIV diseaseC Piketty, P Castiel, L Belec, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavirT Bommenel, O Launay, J L Meynard, et al.
Pageof 4